Epidemiological Data on Mast Cell Pathologies in France
Recruiting
Observational Study
Mast Cell Disorder
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 13,000 (estimated)
- Sponsor
- Imagine Institute · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Mast cell disorders constitute a heterogeneous group of diseases, including :
* mastocytosis, i.e. cutaneous, indolent and severe forms of the disease, such as aggressive mastocytosis and mast cell leukemia) ;
* mast cell-associated diseases such as mast cell activation syndrome (idiopathic, secondary or clonal), affecting both children and adults.
No epidemiological data are currently available…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Children from birth and adults of any age
2. With one of the following mast cell diseases:
* Mastocytoses (cutaneous, systemic and sarcomas) Defined according to the WHO 2016 classification
* Mast cell activation syndromes (idiopathic, secondary and clonal)
* Other …
Contacts